Cargando…
Development of a new quantification method using partial volume effect correction for individual energy peaks in (111)In-pentetreotide SPECT/CT
OBJECTIVE(S): Somatostatin receptor scintigraphy (SRS) using (111)In-pentetreotide has no established quantification method. The purpose of this study was to develop a new quantitative method to correct the partial volume effect (PVE) for individual energy peaks in (111)In-pentetreotide single-photo...
Autores principales: | Yamashita, Kosuke, Miyaji, Noriaki, Motegi, Kazuki, Terauchi, Takashi, Ito, Shigeki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205847/ https://www.ncbi.nlm.nih.gov/pubmed/35800427 http://dx.doi.org/10.22038/AOJNMB.2022.61394.1430 |
Ejemplares similares
-
Automatic and manual image fusion of (111)In-pentetreotide SPECT and diagnostic CT in neuroendocrine tumor imaging – An evaluation
por: Hedlund, Elisabeth, et al.
Publicado: (2010) -
False-positive (111)In-pentetreotide Uptake in Gastritis
por: Usmani, Sharjeel, et al.
Publicado: (2013) -
Cost-Effectiveness Analysis of (68)Ga DOTA-TATE PET/CT, (111)In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors
por: Froelich, Matthias Frank, et al.
Publicado: (2021) -
Sarcoidosis mimicking metastatic carinoid on indium-111 pentetreotide scintigraphy
por: Rafiei, Poyan, et al.
Publicado: (2015) -
Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT
por: Resch, Katrin, et al.
Publicado: (2022)